LT
Latigo Biotherapeutics Inc.
LTGO · NASDAQ
$22.55 -6.74% (-$1.63)
1M +2.50%
Valuation
-
N/A P/B N/A
EV/FFO N/A
P/E N/A
Growth
-
N/A Book val. growth N/A
FCF growth N/A
EPS growth N/A
Profitability
-
N/A FCF margin N/A
Op. margin N/A
Gross margin N/A
Quality
-
N/A Asset turnover N/A
ROA N/A
ROIC N/A
Debt
-
N/A Net debt/EBITDA N/A
Int. coverage N/A
Debt/Equity N/A
Stability
0 /100
Unstable Beta 0.00x
EPS volatility N/A
Profitable years N/A
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about LTGO
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Nima Farzan
Employees
59
Headquarters
Thousand Oak